Yige Guo Ph.d

Yige Guo Ph.D, CFA, currently serves as Associate Director of External Innovation at Vertex Pharmaceuticals since January 2025. Prior to this role, Yige Guo held the position of Vice President of Biotechnology Equity Research at Guggenheim Partners from July 2018 to December 2024, focusing on SMID-cap biotechnology with an emphasis on oncology. Earlier experience includes serving as a Senior Associate in Biotechnology Equity Research at EMD Serono, Inc., where Yige Guo conducted translational research in the DNA Damage Response team, and as a Postdoctoral Research Scientist at Columbia University Medical Center. Additionally, Yige Guo was a Summer Associate at UBS in 2012. Academic credentials include a Ph.D. in Pathobiology and Molecular Medicine from Columbia University and a Bachelor of Science in Biological Sciences from Peking University.